Aster Capital Management (DIFC) Ltd

Position in BMY — Bristol Myers Squibb Co

CIK 2040915 DUBAI, C0

Position in BMY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$536,442

-$468,514 QoQ

Shares Held

9,310

-50.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#1,489

of 2,506 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aster Capital Management (DIFC) Ltd holds $6,794,637 across 4 Drug Manufacturers - General names. BMY ranks #3 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,629	$4,352,731
2	JNJ	Johnson & Johnson	6,824	$1,733,091
3	BMY	Bristol Myers Squibb Co This page	9,310	$536,442
4	ABBV	AbbVie Inc.	685	$172,373

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$536,442	9,310	-50.0%	Shares	Sole	2026-08-14
2025-12-31	$1,004,956	18,631	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.